A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

NCT05677893 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)

Interventions

DRUG: MBS-COV
OTHER: Placebo

Sponsor

Oneness Biotech Co., Ltd.